Wie hoch ist der Preis für Poolbeg Pharma PLC (POLB)

Preis für Poolbeg Pharma PLC (POLB) ist $0.11565963

Wie hoch ist die Marktkapitalisierung für Poolbeg Pharma PLC (POLB)

Marktkapitalisierung für Poolbeg Pharma PLC (POLB) ist $882.99K

Poolbeg Pharma PLC (POLB) Preis und Marktkapitalisierung

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.

Preis für POLB	Vermögenswert B	Marktkapitalisierung von B	Ergebnisse
$714,729 $882.99K	NVDA	$5.457T	+617,959,026.73%
$587,248 $882.99K	AAPL	$4.483T	+507,738,036.93%
$545,096 $882.99K	GOOG	$4.161T	+471,292,844.65%
$482,915 $882.99K	MSFT	$3.687T	+417,530,730.81%
$371,295 $882.99K	AMZN	$2.835T	+321,023,788.21%

Preis für POLB

Vermögenswert B

Marktkapitalisierung von B

Ergebnisse

$714,729 $882.99K